Trailing-twelve-month (TTM) revenue is $105.59 Million with a year-over-year growth of +81.49%. Revenue represents the total income generated from the company's primary business operations.
Trailing-12-month revenue adds these four fiscal quarters. Amounts are in USD, rounded only to whole currency units.
| Fiscal period | Revenue | Source |
|---|---|---|
| Q3 FY2025Period ended 2025-09-30 | $22,459,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2025-11-06 |
| Q4 FY2025Period ended 2025-12-31 | $21,281,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-03-19 |
| Q1 FY2026Period ended 2026-03-31 | $24,266,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-05-14 |
| Q2 FY2026Period ended 2026-06-30 | $37,589,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-08-13 |
| TTM revenue | $105,595,000 |
Current P/S: $1,508,921,737 market capitalization ÷ $105,595,000 TTM revenue = 14.29x.
Market capitalization source: FMP quote. Quote observed 2026-10-06T15:05:03.000Z. Latest revenue period ended 2026-06-30.
Current market capitalization comes from the quote provider. EPS weighted-average shares are a separate measure.
These references are supplied through FMP. Full filing context identifiers and dimensional metadata are unavailable in the normalized feed.
Reported quarterly revenue; no daily interpolation. Q2 FY2026 (2026-06-30): $37.59M.
FMP quote market capitalization / revenue from four consecutive issuer fiscal quarters Quote observation: 2026-10-06T15:06:33.279Z. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2026-10-05.
Selected amounts supplied by FMP for each displayed period. Reviewed label references appear where available; other labels are unverified, and items may overlap.
2025-12-31 · USD
Reviewed labels link to their filing; other labels are unverified FMP source labels.
Reviewed presentation labels and parent/child details link to filing evidence; other FMP source labels remain unverified. Mutual exclusivity and reconciliation to a total for the same reporting period and currency have not been verified; percentages and stacked totals are unavailable.
FMP selected disclosures by reporting period. Rows match exact source labels; they may overlap. N/A means no matching disclosure, not zero. Filing links identify reviewed presentation labels for that period.
| FMP source label (unverified unless linked) | FY20192019-12-31 · USD | FY20212021-12-31 · USD | FY20222022-12-31 · USD | FY20232023-12-31 · USD | FY20242024-12-31 · USD | FY20252025-12-31 · USD |
|---|---|---|---|---|---|---|
| License | N/A | N/A | N/A | $6M | $500,000 | $3M |
| Licensing Revenue | $500,000 | $19M | $10M |
$105.59M
$105.59 Million
+81.49%
vs. $58.18M a year ago (TTM)
+47.98%
5 Year compound annual growth rate
1 Year
+81.49%
3 Year
+53.80%
5 Year
+47.98%
10 Year
N/A
15 Year
N/A
20 Year
N/A
CAGR shows the annualized growth rate over the specified period, smoothing out year-to-year volatility.
| Year | Revenue | YoY Change | % Change |
|---|---|---|---|
| 2025 | $79.95M | +$40.94M | +104.94% |
| 2024 | $39.01M | +$7.37M | +23.29% |
| 2023 | $31.64M | +$10.39M | +48.90% |
| 2022 | $21.25M | ($581,000) | (2.66%) |
| 2021 | $21.83M | +$21.79M | +55879.49% |
| 2020 |
TTM Growth
+81.49%
3-Year CAGR
+53.80%
5-Year CAGR
+47.98%
Revenue growth vs the same fiscal quarter in the prior fiscal year, last 18 comparable quarters.
Current FMP quote-based enterprise value / four-quarter revenue Quote observation: 2026-10-06T15:06:33.279Z. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2026-10-05.
| N/A |
| N/A |
| N/A |
| Product Sales and Royalties | N/A | N/A | N/A | $26M | $39M | $77M |
|---|
| $39,000 |
| ($920,000) |
| (95.93%) |
